{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:44:17Z","timestamp":1791863057060,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860506"],"award-info":[{"award-number":["81860506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960433"],"award-info":[{"award-number":["81960433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Project of Science and Technology of Guizhou Province","award":["Qian Ke He Zhi Cheng [2021] normal 080"],"award-info":[{"award-number":["Qian Ke He Zhi Cheng [2021] normal 080"]}]},{"name":"Science and Technology Fund of Guizhou Provincial Health and Family Planning Commission","award":["gzwkj2021-167"],"award-info":[{"award-number":["gzwkj2021-167"]}]},{"name":"Guiyang Science and technology project","award":["Zhu Ke He Tong [2019]9-1-26"],"award-info":[{"award-number":["Zhu Ke He Tong [2019]9-1-26"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>MICAL1 is involved in the malignant processes of several types of cancer; however, the role of MICAL1 in pancreatic cancer (PC) has not been well-characterized. This study aimed to investigate the expression and function of MICAL1 in PC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RT-qPCR and immunohistochemistry were used to detect MICAL1 expression in PC and adjacent nontumor tissues. Cell Counting Kit-8, EdU, clone formation, wound healing, and Transwell assays as well as animal models were used to investigate the effects of overexpression or inhibition of MICAL1 expression on the proliferation, invasion, and metastasis of PC cells. RNA-seq was used to explore the main pathway underlying the functions of MICAL1. Proteomics, mass spectrometry, and co-immunoprecipitation assays were used to investigate the interaction of proteins with MICAL1. Rescue experiments were conducted to validate these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both MICAL1 mRNA and protein levels were upregulated in PC tissues compared with matched adjacent nontumor tissues. The expression level of MICAL1 was associated with the proliferative and metastatic status of PC. Repression of MICAL1 significantly inhibited PC cell growth, migration, and invasion in vitro and in vivo. RNA sequencing analysis indicated that MICAL1 was closely correlated with the WNT pathway. Overexpression of MICAL1 (1) promoted the phosphorylation of TBC1D1 at the Ser660 site, (2) facilitated the distribution of FZD7 on the cytomembrane, (3) inhibited the degradation of FZD7 in the lysosome, and (4) activated the WNT pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MICAL1 was upregulated in PC and involved in stimulating the progression of PC cells by activating the WNT\/\u03b2-catenin signaling pathway. Therefore, MICAL1 is a potential therapeutic target for PC.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-022-03749-1","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:03:04Z","timestamp":1668243784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT\/\u03b2-catenin pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Kun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-9416","authenticated-orcid":false,"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"3749_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18859","author":"S Gaddam","year":"2021","unstructured":"Gaddam S, Abboud Y, Oh J, et al. Incidence of pancreatic cancer by age and sex in the US, 2000\u20132018. JAMA. 2021. https:\/\/doi.org\/10.1001\/jama.2021.18859.","journal-title":"JAMA"},{"issue":"2","key":"3749_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41575-020-00410-4","volume":"18","author":"T Jain","year":"2021","unstructured":"Jain T, Dudeja V. The war against pancreatic cancer in 2020 - advances on all fronts. Nat Rev Gastroenterol Hepatol. 2021;18(2):99\u2013100.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3749_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18(11):804\u201323.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"3749_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly E. Pancreatic cancer: a review. JAMA. 2021;326(9):851\u201362.","journal-title":"JAMA"},{"key":"3749_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00418-1","author":"AA Connor","year":"2021","unstructured":"Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2021. https:\/\/doi.org\/10.1038\/s41568-021-00418-1.","journal-title":"Nat Rev Cancer"},{"key":"3749_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326311","author":"CJ Cabasag","year":"2021","unstructured":"Cabasag CJ, Ferlay J, Laversanne M, et al. Pancreatic cancer: an increasing global public health concern. Gut. 2021. https:\/\/doi.org\/10.1136\/gutjnl-2021-326311.","journal-title":"Gut"},{"issue":"9","key":"3749_CR7","doi-asserted-by":"publisher","first-page":"R538","DOI":"10.1016\/j.cub.2018.01.025","volume":"28","author":"LT Alto","year":"2018","unstructured":"Alto LT, Terman JR. MICALs. Curr Biol. 2018;28(9):R538\u201341.","journal-title":"Curr Biol"},{"issue":"24","key":"3749_CR8","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1007\/s00018-011-0787-2","volume":"68","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Gunput RA, Adolfs Y, Pasterkamp RJ. MICALs in control of the cytoskeleton, exocytosis, and cell death. Cell Mol Life Sci. 2011;68(24):4033\u201344.","journal-title":"Cell Mol Life Sci"},{"key":"3749_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12885-016-2553-1","volume":"16","author":"W Deng","year":"2016","unstructured":"Deng W, Wang Y, Gu L, et al. MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells. BMC Cancer. 2016;16:489.","journal-title":"BMC Cancer"},{"issue":"6","key":"3749_CR10","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/jcmm.13588","volume":"22","author":"W Deng","year":"2018","unstructured":"Deng W, Wang Y, Zhao S, et al. MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK\/cyclin D pathway. J Cell Mol Med. 2018;22(6):3108\u201318.","journal-title":"J Cell Mol Med"},{"key":"3749_CR11","doi-asserted-by":"publisher","first-page":"114870","DOI":"10.1016\/j.bcp.2021.114870","volume":"195","author":"H Gu","year":"2021","unstructured":"Gu H, Li Y, Cui X, et al. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1\/beta-catenin signaling pathway. Biochem Pharmacol. 2021;195:114870.","journal-title":"Biochem Pharmacol"},{"key":"3749_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2021.07.039","volume":"519","author":"DJ McGarry","year":"2021","unstructured":"McGarry DJ, Armstrong G, Castino G, et al. MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours. Cancer Lett. 2021;519:226\u201336.","journal-title":"Cancer Lett"},{"issue":"5","key":"3749_CR13","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/db14-0719","volume":"64","author":"PK Aggarwal","year":"2015","unstructured":"Aggarwal PK, Veron D, Thomas DB, et al. Semaphorin3a promotes advanced diabetic nephropathy. Diabetes. 2015;64(5):1743\u201359.","journal-title":"Diabetes"},{"issue":"1","key":"3749_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12879-016-1822-6","volume":"16","author":"XB Qin","year":"2016","unstructured":"Qin XB, Zhang WJ, Zou L, Huang PJ, Sun BJ. Identification potential biomarkers in pulmonary tuberculosis and latent infection based on bioinformatics analysis. BMC Infect Dis. 2016;16(1):500.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3749_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/ana.25167","volume":"83","author":"E Dazzo","year":"2018","unstructured":"Dazzo E, Rehberg K, Michelucci R, et al. Mutations in MICAL-1cause autosomal-dominant lateral temporal epilepsy. Ann Neurol. 2018;83(3):483\u201393.","journal-title":"Ann Neurol"},{"issue":"9","key":"3749_CR16","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1172\/JCI133181","volume":"130","author":"K Konstantinidis","year":"2020","unstructured":"Konstantinidis K, Bezzerides VJ, Lai L, et al. MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII. J Clin Invest. 2020;130(9):4663\u201378.","journal-title":"J Clin Invest"},{"key":"3749_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fphar.2019.00291","volume":"10","author":"S Zhao","year":"2019","unstructured":"Zhao S, Min P, Liu L, et al. NEDD9 facilitates hypoxia-induced gastric cancer cell migration via MICAL1 related Rac1 activation. Front Pharmacol. 2019;10:291.","journal-title":"Front Pharmacol"},{"issue":"10","key":"3749_CR18","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1158\/2159-8290.CD-21-0190","volume":"11","author":"MJ Parsons","year":"2021","unstructured":"Parsons MJ, Tammela T, Dow LE. WNT as a driver and dependency in cancer. Cancer Discov. 2021;11(10):2413\u201329.","journal-title":"Cancer Discov"},{"issue":"1","key":"3749_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"3749_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.tips.2018.07.001","volume":"39","author":"G Schulte","year":"2018","unstructured":"Schulte G, Wright SC. Frizzleds as GPCRs\u2014more conventional than we thought! Trends Pharmacol Sci. 2018;39(9):828\u201342.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3749_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, et al. Wnt\/beta-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3749_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3727\/096504020X16014648664459","volume":"28","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wang W, Zhao C. Frizzled receptors in tumors, focusing on signaling, roles, modulation mechanisms, and targeted therapies. Oncol Res. 2021;28(6):661\u201374.","journal-title":"Oncol Res"},{"issue":"Pt B","key":"3749_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejphar.2015.05.031","volume":"763","author":"G Schulte","year":"2015","unstructured":"Schulte G. Frizzleds and WNT\/beta-catenin signaling\u2013The black box of ligand-receptor selectivity, complex stoichiometry and activation kinetics. Eur J Pharmacol. 2015;763(Pt B):191\u20135.","journal-title":"Eur J Pharmacol"},{"key":"3749_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.12.008","author":"Y Larasati","year":"2022","unstructured":"Larasati Y, Boudou C, Koval A, Katanaev VL. Unlocking the Wnt pathway: therapeutic potential of selective targeting FZD7 in cancer. Drug Discov Today. 2022. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.008.","journal-title":"Drug Discov Today"},{"issue":"7","key":"3749_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-021-00479-5","volume":"18","author":"Advancing on pancreatic cancer","year":"2021","unstructured":"Advancing on pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2021;18(7):447.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"3749_CR26","doi-asserted-by":"publisher","first-page":"e50965","DOI":"10.15252\/embr.202050965","volume":"22","author":"H Wioland","year":"2021","unstructured":"Wioland H, Fremont S, Guichard B, Echard A, Jegou A, Romet-Lemonne G. Actin filament oxidation by MICAL1 suppresses protections from cofilin-induced disassembly. EMBO Rep. 2021;22(2):e50965.","journal-title":"EMBO Rep"},{"issue":"9","key":"3749_CR27","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1242\/jcs.202028","volume":"130","author":"S Fremont","year":"2017","unstructured":"Fremont S, Romet-Lemonne G, Houdusse A, Echard A. Emerging roles of MICAL family proteins\u2014from actin oxidation to membrane trafficking during cytokinesis. J Cell Sci. 2017;130(9):1509\u201317.","journal-title":"J Cell Sci"},{"issue":"3","key":"3749_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.molcel.2013.06.019","volume":"51","author":"BC Lee","year":"2013","unstructured":"Lee BC, Peterfi Z, Hoffmann FW, et al. MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol Cell. 2013;51(3):397\u2013404.","journal-title":"Mol Cell"},{"issue":"8","key":"3749_CR29","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1073\/pnas.1911629117","volume":"117","author":"J Bai","year":"2020","unstructured":"Bai J, Wioland H, Advedissian T, Cuvelier F, Romet-Lemonne G, Echard A. Actin reduction by MsrB2 is a key component of the cytokinetic abscission checkpoint and prevents tetraploidy. Proc Natl Acad Sci U S A. 2020;117(8):4169\u201379.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3749_CR30","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.18632\/oncotarget.2995","volume":"6","author":"R Loria","year":"2015","unstructured":"Loria R, Bon G, Perotti V, et al. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget. 2015;6(5):2779\u201393.","journal-title":"Oncotarget"},{"issue":"2","key":"3749_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrm3267","volume":"13","author":"MA Frasa","year":"2012","unstructured":"Frasa MA, Koessmeier KT, Ahmadian MR, Braga VM. Illuminating the functional and structural repertoire of human TBC\/RABGAPs. Nat Rev Mol Cell Biol. 2012;13(2):67\u201373.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"3749_CR32","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1002\/anie.201900585","volume":"59","author":"JL Gray","year":"2020","unstructured":"Gray JL, von Delft F, Brennan PE. Targeting the small GTPase superfamily through their regulatory proteins. Angew Chem Int Ed Engl. 2020;59(16):6342\u201366.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7618","key":"3749_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature19326","volume":"537","author":"DH Murray","year":"2016","unstructured":"Murray DH, Jahnel M, Lauer J, et al. An endosomal tether undergoes an entropic collapse to bring vesicles together. Nature. 2016;537(7618):107\u201311.","journal-title":"Nature"},{"key":"3749_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-biochem-060109-094246","volume":"81","author":"JS Bogan","year":"2012","unstructured":"Bogan JS. Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem. 2012;81:507\u201332.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"3749_CR35","doi-asserted-by":"publisher","first-page":"17953","DOI":"10.1038\/s41598-020-74661-1","volume":"10","author":"SC Hook","year":"2020","unstructured":"Hook SC, Chadt A, Heesom KJ, et al. TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. Sci Rep. 2020;10(1):17953.","journal-title":"Sci Rep"},{"issue":"8","key":"3749_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tem.2017.05.002","volume":"28","author":"JR Jaldin-Fincati","year":"2017","unstructured":"Jaldin-Fincati JR, Pavarotti M, Frendo-Cumbo S, Bilan PJ, Klip A. Update on GLUT4 vesicle traffic: a cornerstone of insulin action. Trends Endocrinol Metab. 2017;28(8):597\u2013611.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"3749_CR37","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/ng.244","volume":"40","author":"A Chadt","year":"2008","unstructured":"Chadt A, Leicht K, Deshmukh A, et al. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet. 2008;40(11):1354\u20139.","journal-title":"Nat Genet"},{"issue":"11","key":"3749_CR38","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.2337\/db20-0180","volume":"69","author":"T Benninghoff","year":"2020","unstructured":"Benninghoff T, Espelage L, Eickelschulte S, et al. The RabGAPs TBC1D1 and TBC1D4 control uptake of long-chain fatty acids into skeletal muscle via fatty acid transporter SLC27A4\/FATP4. Diabetes. 2020;69(11):2281\u201393.","journal-title":"Diabetes"},{"issue":"1","key":"3749_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41467-019-14149-3","volume":"11","author":"P Kozielewicz","year":"2020","unstructured":"Kozielewicz P, Turku A, Bowin CF, et al. Structural insight into small molecule action on Frizzleds. Nat Commun. 2020;11(1):414.","journal-title":"Nat Commun"},{"issue":"7653","key":"3749_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature22306","volume":"545","author":"CY Janda","year":"2017","unstructured":"Janda CY, Dang LT, You C, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature. 2017;545(7653):234\u20137.","journal-title":"Nature"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03749-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T01:39:43Z","timestamp":1728351583000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03749-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03749-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University, Guiyang, China. All animal studies were approved by the Animal Experimental Ethics Committee of Guizhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}